BridgeMD
New treatment option for Postoperative Pain, Acute
Official title Meloxicam in Mohs Micrographic Surgery
ClinicalTrials.gov ID: NCT07200544
What this study is testing
What is Meloxicam 7.5 mg?
Meloxicam 7.5 mg is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for postoperative pain, acute.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to explore alternative methods of postoperative pain control in Mohs micrographic surgery. The main aims are: To provide more information to the Mohs surgery community regarding postoperative pain control.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110
You may be able to join if
- All adult patients who consents to the study and are undergoing Mohs micrographic surgery at the University of Oklahoma.
You likely can't join if
- Women who are pregnant, suspected to be pregnant, or planning to become pregnant during the study period will be excluded from participation.
- Chronic liver disease (chronic hepatitis, acute hepatitis, cirrhosis, NASH, NAFLD, alcoholic liver disease, hemochromatosis, Wilson's disease)
- Chronic kidney disease stage III or greater,
- Aspirin-sensitive asthma
- History of chronic NSAID use
- Patients vulnerable to drug interactions
See the full eligibility criteria
- All adult patients who consents to the study and are undergoing Mohs micrographic surgery at the University of Oklahoma.
- Women who are pregnant, suspected to be pregnant, or planning to become pregnant during the study period will be excluded from participation.
- Chronic liver disease (chronic hepatitis, acute hepatitis, cirrhosis, NASH, NAFLD, alcoholic liver disease, hemochromatosis, Wilson's disease)
- Chronic kidney disease stage III or greater,
- Aspirin-sensitive asthma
- History of chronic NSAID use
- Patients vulnerable to drug interactions
- GI bleeds
- Peptic ulcers
- Non-English speakers
The study team makes the final eligibility decision.
Where it's taking place
- Oklahoma City, Oklahoma, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oklahoma City, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.